| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.22 | 1e-06 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |